{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:00:11Z","timestamp":1791090011449,"version":"4.1.0"},"reference-count":152,"publisher":"The Endocrine Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,4,1]]},"DOI":"10.1210\/edrv.22.2.0427","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T18:26:37Z","timestamp":1389205597000},"page":"240-254","source":"Crossref","is-referenced-by-count":57,"title":["The Effects of Amiodarone on the Thyroid*"],"prefix":"10.1210","volume":"22","author":[{"given":"Enio","family":"Martino","sequence":"first","affiliation":[{"name":"Dipartimento di Endocrinologia e Metabolismo (E.M., F.B.), University of Pisa, Pisa, Italy 56124"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Bartalena","sequence":"additional","affiliation":[{"name":"Cattedra di Endocrinologia (L.B.), University of Insubria, Varese, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fausto","family":"Bogazzi","sequence":"additional","affiliation":[{"name":"Dipartimento di Endocrinologia e Metabolismo (E.M., F.B.), University of Pisa, Pisa, Italy 56124"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis E.","family":"Braverman","sequence":"additional","affiliation":[{"name":"Section of Endocrinology, Diabetes and Nutrition (L.E.B.), Boston Medical Center, Boston, Massachusetts 02118-2393"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2016,11,7]]},"reference":[{"key":"2019041122200052900_R1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/clc.4960170303","article-title":"A consensus report on antiarrhythmic drug use.","volume":"17","author":"Reiffel","year":"1994","journal-title":"Clin Cardiol"},{"key":"2019041122200052900_R2","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(94)91895-3","article-title":"Randomized trial of low-dose amiodarone in severe congestive heart failure.","volume":"344","author":"Doval","year":"1994","journal-title":"Lancet"},{"key":"2019041122200052900_R3","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/0735-1097(92)90357-S","article-title":"Effect of amiodarone on mortality after myocardial infarction: a double-blind, placebo-controlled, pilot study.","volume":"20","author":"Ceremuzynski","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"2019041122200052900_R4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM199507133330201","article-title":"Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmias. Survival trial of antiarrhythmic therapy in congestive heart failure.","volume":"333","author":"Singh","year":"1995","journal-title":"N Engl J Med"},{"key":"2019041122200052900_R5","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1056\/NEJM199712183372501","article-title":"Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery.","volume":"337","author":"Daoud","year":"1997","journal-title":"N Engl J Med"},{"key":"2019041122200052900_R6","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJM200003303421302","article-title":"Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators.","volume":"342","author":"Roy","year":"2000","journal-title":"N Engl J Med"},{"key":"2019041122200052900_R7","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1056\/NEJM199909163411203","article-title":"Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation.","volume":"341","author":"Kudenchuk","year":"1999","journal-title":"N Engl J Med"},{"key":"2019041122200052900_R8","first-page":"24","article-title":"Amiodarone and the thyroid: the Janus response.","volume":"2","year":"1987","journal-title":"Lancet"},{"key":"2019041122200052900_R9","first-page":"225","author":"Wiersinga","year":"1997"},{"key":"2019041122200052900_R10","first-page":"1","article-title":"Amiodarone and the thyroid.","volume":"13","author":"Lombardi","year":"1990","journal-title":"Thyroid Today"},{"key":"2019041122200052900_R11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.7326\/0003-4819-126-1-199701010-00009","article-title":"Effects of amiodarone on thyroid function.","volume":"126","author":"Harjai","year":"1997","journal-title":"Ann Intern Med"},{"key":"2019041122200052900_R12","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/00019616-199905000-00008","article-title":"Amiodarone-induced thyroid dysfunction.","volume":"9","author":"Iudica-Souza","year":"1999","journal-title":"The Endocrinologist"},{"key":"2019041122200052900_R13","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1210\/jcem-62-3-563","article-title":"Iodine kinetic studies during amiodarone treatment","volume":"62","author":"Rao","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122200052900_R14","first-page":"295","author":"Delange","year":"2000"},{"key":"2019041122200052900_R15","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0002-8703(83)90006-6","article-title":"Amiodarone pharmacokinetics.","volume":"106","author":"Holt","year":"1983","journal-title":"Am Heart J"},{"key":"2019041122200052900_R16","first-page":"513","article-title":"Pharmacokinetics and body distribution of amiodarone in man.","volume":"34","author":"Plomp","year":"1984","journal-title":"Arzneimittelforschung\/Drug Res"},{"key":"2019041122200052900_R17","first-page":"45","author":"Berger","year":"1986"},{"key":"2019041122200052900_R18","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1210\/endo-113-4-1464","article-title":"The effects of amiodarone on serum thyroid hormones and hepatic 5\u2032-deiodinase.","volume":"113","author":"Sogol","year":"1983","journal-title":"Endocrinology"},{"key":"2019041122200052900_R19","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1210\/endo-115-4-1605","article-title":"Amiodarone inhibits the conversion of thyroxine to triiodothyronine in isolated rat hepatocytes.","volume":"115","author":"Aanderaud","year":"1984","journal-title":"Endocrinology"},{"key":"2019041122200052900_R20","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1530\/acta.0.1110193","article-title":"Thyroxine and triiodothyronine kinetics in cardiac patients taking amiodarone.","volume":"111","author":"Hershman","year":"1986","journal-title":"Acta Endocrinol (Copenh)"},{"key":"2019041122200052900_R21","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1210\/jcem-70-6-1721","article-title":"Amiodarone does not affect the distribution and fractional turnover of triiodothyronine from the plasma pool, but only its generation from thyroxine in extrathyroidal tissues.","volume":"70","author":"Zaninovich","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122200052900_R22","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0014-5793(82)80900-9","article-title":"Decreased transport of thyroxine (T4), 3,3\u2032,5-triiodothyronine (T3) and 3,3\u2032,5\u2032-triiodothyronine (rT3) into rat hepatocytes in primary culture due to a decrease of cellular ATP content and various drugs.","volume":"140","author":"Krenning","year":"1982","journal-title":"FEBS Lett"},{"key":"2019041122200052900_R23","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1001\/archinte.1984.00350150071023","article-title":"Clinical and chemical assessment of thyroid function during therapy with amiodarone.","volume":"144","author":"Amico","year":"1984","journal-title":"Arch Intern Med"},{"key":"2019041122200052900_R24","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1172\/JCI108466","article-title":"Effect of amiodarone on serum triiodothyronine, reverse triiodothyronine, thyroxin, and thyrotropin.","volume":"58","author":"Burger","year":"1976","journal-title":"J Clin Invest"},{"key":"2019041122200052900_R25","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1210\/jcem-53-5-997","article-title":"Hyperthyroxinemia with bradycardia and normal thyrotropin secretion after chronic amiodarone administration.","volume":"53","author":"Melmed","year":"1981","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122200052900_R26","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0002-9149(86)80023-6","article-title":"Amiodarone, thyroid hormone indexes, and altered thyroid function: long-term serial effects in patients with cardiac arrhythmias.","volume":"58","author":"Nademanee","year":"1986","journal-title":"Am J Cardiol"},{"key":"2019041122200052900_R27","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-2265.1985.tb03238.x","article-title":"Amiodarone and thyroid hormone function.","volume":"22","author":"Franklyn","year":"1985","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041122200052900_R28","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/00000441-198609000-00003","article-title":"Effects of amiodarone and desethylamiodarone on pituitary deiodinase activity and thyrotropin secretion in the rat.","volume":"29","author":"Safran","year":"1986","journal-title":"Am J Med Sci"},{"key":"2019041122200052900_R29","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1210\/jcem.82.1.3675","article-title":"Acute effects of amiodarone administration on thyroid function in patients with cardiac arrhythmia.","volume":"82","author":"Iervasi","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122200052900_R30","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1210\/endo.134.5.8156930","article-title":"Studies on the in vitro cytotoxic effect of amiodarone.","volume":"134","author":"Chiovato","year":"1994","journal-title":"Endocrinology"},{"key":"2019041122200052900_R31","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1016\/0006-2952(89)90648-5","article-title":"Cytotoxic effects of amiodarone and desethylamiodarone on human thyrocytes.","volume":"38","author":"Beddows","year":"1989","journal-title":"Biochem Pharmacol"},{"key":"2019041122200052900_R32","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1210\/endo.141.2.7291","article-title":"Iodide excess induces apoptosis in thyroid cells through a p53-independent mechanism involving oxidative stress.","volume":"141","author":"Vitale","year":"2000","journal-title":"Endocrinology"},{"key":"2019041122200052900_R33","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1530\/eje.0.1370089","article-title":"Amiodarone induces a different pattern of ultrastructural change in the thyroid to iodine excess alone in both the BB\/W rat and the Wistar rat","volume":"137","author":"Pitsiavas","year":"1997","journal-title":"1997 Eur J Endocrinol"},{"key":"2019041122200052900_R34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1530\/eje.0.1370015","article-title":"Towards an animal model of amiodarone-induced thyroid dysfunction.","volume":"137","author":"Wiersinga","year":"1997","journal-title":"Eur J Endocrinol"},{"key":"2019041122200052900_R35","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/0002-8703(86)90473-4","article-title":"Amiodarone-induced ultrastructural changes in canine myocardial fibers.","volume":"112","author":"Gross","year":"1986","journal-title":"Am Heart J"},{"key":"2019041122200052900_R36","first-page":"209","author":"McGregor","year":"1985"},{"key":"2019041122200052900_R37","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1126\/science.4048936","article-title":"Induction of autoimmune thyroiditis by dietary iodine.","volume":"230","author":"Bagchi","year":"1985","journal-title":"Science"},{"key":"2019041122200052900_R38","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1210\/endo-118-5-1977","article-title":"The effect of iodide ingestion on the development of spontaneous lymphocytic thyroiditis in the diabetes-prone BB\/W rat.","volume":"118","author":"Allen","year":"1986","journal-title":"Endocrinology"},{"key":"2019041122200052900_R39","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/bmj.292.6515.227","article-title":"Antithyroid antibodies as an early marker for thyroid disease induced by amiodarone.","volume":"292","author":"Monteiro","year":"1986","journal-title":"Br Med J Clinical Research Edition"},{"key":"2019041122200052900_R40","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1136\/bmj.297.6646.456","article-title":"Effect of amiodarone on circulating antithyroid antibodies.","volume":"297","author":"Safran","year":"1988","journal-title":"Br Med J"},{"key":"2019041122200052900_R41","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1136\/bmj.297.6640.33","article-title":"Amiodarone and thyroid autoimmunity in the United Kingdom.","volume":"297","author":"Weetman","year":"1988","journal-title":"Br Med J"},{"key":"2019041122200052900_R42","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/BF03350159","article-title":"Absence of serum thyroid hormone autoantibodies in patients chronically treated with amiodarone.","volume":"11","author":"Loviselli","year":"1988","journal-title":"J Endocrinol Invest"},{"key":"2019041122200052900_R43","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1530\/acta.0.1210203","article-title":"Antithyroid antibodies during amiodarone treatment.","volume":"121","author":"Foresti","year":"1989","journal-title":"Acta Endocrinol (Copenh)"},{"key":"2019041122200052900_R44","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0002-9343(91)90187-3","article-title":"Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism.","volume":"91","author":"Trip","year":"1991","journal-title":"Am J Med"},{"key":"2019041122200052900_R45","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0002-9343(86)90181-6","article-title":"Amiodarone therapy and autoimmune thyroid disease. Increase in a new monoclonal antibody-defined T cell subset.","volume":"81","author":"Rabinowe","year":"1986","journal-title":"Am J Med"},{"key":"2019041122200052900_R46","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1210\/endo-127-6-2930","article-title":"Amiodarone effects on thyrotropin receptors and responses stimulated by thyrotropin and carbachol in cultured dog thyroid cells.","volume":"127","author":"Rani","year":"1990","journal-title":"Endocrinology"},{"key":"2019041122200052900_R47","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/0006-2952(91)90212-N","article-title":"Regulation of beta-adrenoceptors by thyroid hormone and amiodarone in rat myocardiac cells in culture.","volume":"41","author":"Disatnik","year":"1991","journal-title":"Biochem Pharmacol"},{"key":"2019041122200052900_R48","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1055\/s-2007-1004857","article-title":"Amiodarone reduces the effect of T3 on \u03b2-adrenergic receptor density in rat heart.","volume":"22","author":"Hartong","year":"1990","journal-title":"Horm Metab Res"},{"key":"2019041122200052900_R49","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1530\/acta.0.1290337","article-title":"\u03b2-adrenergic receptors, voltage-operated Ca2+ channels, nuclear triiodothyronine receptors and triiodothyronine concentration in pig myocardium after long-term low-dose amiodarone treatment.","volume":"129","author":"Gotzsche","year":"1993","journal-title":"Acta Endocrinol (Copenh)"},{"key":"2019041122200052900_R50","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/00005344-199204000-00010","article-title":"In vivo effects of amiodarone on cardiac \u03b2 -adrenoceptor density and heart require thyroid hormones.","volume":"19","author":"Yin","year":"1992","journal-title":"J Cardiovasc Pharmacol"},{"key":"2019041122200052900_R51","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1038\/sj.bjp.0702456","article-title":"Interaction of amiodarone and triiodothyronine on the expression of \u03b2-adrenoceptors in brown adipose tissue of rat.","volume":"126","author":"Adli","year":"1999","journal-title":"Br J Pharmacol"},{"key":"2019041122200052900_R52","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/0014-5793(94)80245-9","article-title":"Amiodarone-induced hypercholesterolemia is associated with a decrease in liver LDL receptor mRNA.","volume":"341","author":"Hudig","year":"1994","journal-title":"FEBS Lett"},{"key":"2019041122200052900_R53","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/S0026-0495(98)90277-3","article-title":"Amiodarone decreases gene expression of low-density lipoprotein receptor at both the mRNA and the protein level.","volume":"47","author":"Hudig","year":"1998","journal-title":"Metabolism"},{"key":"2019041122200052900_R54","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1172\/JCI113874","article-title":"Antagonism of thyroid hormone action by amiodarone in rat pituitary tumor cells.","volume":"83","author":"Norman","year":"1989","journal-title":"J Clin Invest"},{"key":"2019041122200052900_R55","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1530\/eje.0.1300281","article-title":"Cardiac triiodothyronine nuclear receptor binding capacities in amiodarone-treated, hypo- and hyperthyroid rats.","volume":"130","author":"Gotzsche","year":"1994","journal-title":"Eur J Endocrinol"},{"key":"2019041122200052900_R56","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00005344-199908000-00012","article-title":"Thyroid hormone \u03b11 and \u03b21 receptor mRNA are downregulated by amiodarone in mouse myocardium.","volume":"34","author":"Shahrara","year":"1999","journal-title":"J Cardiovasc Pharmacol"},{"key":"2019041122200052900_R57","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1210\/endo.134.4.8137729","article-title":"Desethylamiodarone is a noncompetitive inhibitor of the binding of thyroid hormone to the thyroid hormone \u03b21-receptor protein.","volume":"134","author":"Bakker","year":"1994","journal-title":"Endocrinology"},{"key":"2019041122200052900_R58","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0303-7207(95)03578-U","article-title":"Desethylamiodarone Desethylamiodarone is a competitive inhibitor of the binding of thyroid hormone to the thyroid hormone \u03b11-receptor protein.","volume":"112","author":"Van Beeren","year":"1995","journal-title":"Mol Cell Endocrinol"},{"key":"2019041122200052900_R59","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0014-5793(99)00453-6","article-title":"Effect of mutations in the \u03b21-thyroid hormone receptor on the inhibition of T3 binding by desethylamiodarone.","volume":"450","author":"Van Beeren","year":"1999","journal-title":"FEBS Lett"},{"key":"2019041122200052900_R60","author":"Bogazzi","year":"1998"},{"key":"2019041122200052900_R61","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1006\/bbrc.1998.9174","article-title":"Effects of triiodothyronine and amiodarone on the promoter of the human LDL receptor gene.","volume":"19","author":"Bakker","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"2019041122200052900_R62","doi-asserted-by":"crossref","first-page":"28","DOI":"10.7326\/0003-4819-101-1-28","article-title":"Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy.","volume":"101","author":"Martino","year":"1984","journal-title":"Ann Intern Med"},{"key":"2019041122200052900_R63","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000180696","article-title":"Amiodarone: a common source of iodine-induced thyrotoxicosis.","volume":"26","author":"Martino","year":"1987","journal-title":"Horm Res"},{"key":"2019041122200052900_R64","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2265.1987.tb00781.x","article-title":"Amiodarone iodine-induced hypothyroidism: risk factors and follow-up in 28 cases.","volume":"26","author":"Martino","year":"1987","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041122200052900_R65","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1001\/archinte.1994.00420230115013","article-title":"Enhanced susceptibility to amiodarone-induced hypothyroidism in patients with thyroid autoimmune disease.","volume":"154","author":"Martino","year":"1994","journal-title":"Arch Intern Med"},{"key":"2019041122200052900_R66","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF03345479","article-title":"High prevalence of thyroid dysfunction in adult patients with \u03b2 -thalassemia major submitted to amiodarone treatment.","volume":"22","author":"Mariotti","year":"1999","journal-title":"J Endocrinol Invest"},{"key":"2019041122200052900_R67","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0735-1097(87)80098-0","article-title":"Thyroid dysfunction during chronic amiodarone therapy.","volume":"9","author":"Albert","year":"1987","journal-title":"J Am Coll Cardiol"},{"key":"2019041122200052900_R68","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1161\/01.CIR.100.2.149","article-title":"Amiodarone-associated thyroid dysfunction. Risk factors in adults with congenital heart disease.","volume":"100","author":"Thorne","year":"1999","journal-title":"Circulation"},{"key":"2019041122200052900_R69","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1445-5994.1988.tb02237.x","article-title":"Amiodarone-induced hyperthyroidism: assessment of the predictive value of biochemical testing and response to combined therapy with propylthiouracil and perchlorate.","volume":"18","author":"Newnham","year":"1988","journal-title":"Aust NZ J Med"},{"key":"2019041122200052900_R70","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/BF01732171","article-title":"Amiodarone-treated patients with suppressed TSH test are at risk of thyrotoxicosis.","volume":"63","author":"Staubli","year":"1985","journal-title":"Klin Wochenschr"},{"key":"2019041122200052900_R71","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1111\/j.1540-8159.1996.tb03179.x","article-title":"Amiodarone-induced hyperthyroidism: a case series and brief review of literature.","volume":"19","author":"Harjai","year":"1996","journal-title":"Pacing Clin Electrophysiol"},{"key":"2019041122200052900_R72","first-page":"1062","article-title":"Amiodarone-associated thyrotoxicosis: experience with surgical management.","volume":"102","author":"Brennan","year":"1987","journal-title":"Surgery"},{"key":"2019041122200052900_R73","first-page":"627","author":"Martino","year":"1986"},{"key":"2019041122200052900_R74","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1089\/thy.1998.8.1123","article-title":"Amiodarone-induced thyrotoxicosis associated with thyrotropin receptor antibody.","volume":"8","author":"Sato","year":"1998","journal-title":"Thyroid"},{"key":"2019041122200052900_R75","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1210\/jcem-66-4-762","article-title":"Effects of amiodarone therapy on thyroid iodine content as measured by X-ray fluorescence.","volume":"66","author":"Fragu","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122200052900_R76","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1210\/jcem-63-2-485","article-title":"uninhibited thyroidal uptake of radioiodine despite iodine excess in amiodarone-induced hypothyroidism.","volume":"63","author":"Wiersinga","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122200052900_R77","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1530\/acta.0.1190167","article-title":"Radioactive iodine uptake in patients with amiodarone-iodine-induced thyroid dysfunction.","volume":"119","author":"Martino","year":"1988","journal-title":"Acta Endocrinol (Copenh)"},{"key":"2019041122200052900_R78","first-page":"1402","article-title":"Twenty-four hour radioactive iodine uptake in 35 patients with amiodarone associated thyrotoxicosis.","volume":"26","author":"Martino","year":"1985","journal-title":"J Nucl Med"},{"key":"2019041122200052900_R79","first-page":"423","article-title":"Serum interleukin-6 in amiodarone-induced thyrotoxicosis.","volume":"78","author":"Bartalena","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122200052900_R80","first-page":"1424","author":"Bartalena","year":"1994"},{"key":"2019041122200052900_R81","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF03344951","article-title":"Increased serum interleukin-6 concentration in patients with subacute thyroiditis: relationship with concomitant changes in serum T4-binding globulin concentration.","volume":"16","author":"Bartalena","year":"1993","journal-title":"J Endocrinol Invest"},{"key":"2019041122200052900_R82","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1089\/thy.1997.7.541","article-title":"Color flow doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis.","volume":"7","author":"Bogazzi","year":"1997","journal-title":"Thyroid"},{"key":"2019041122200052900_R83","first-page":"215","author":"Bogazzi","year":"2000"},{"key":"2019041122200052900_R84","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1089\/thy.1995.5.177","article-title":"Nongoitrous\/type I) amiodarone-associated thyrotoxicosis: evidence of follicular disruption in vitro and in vivo.","volume":"5","author":"Brennan","year":"1995","journal-title":"Thyroid"},{"key":"2019041122200052900_R85","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00000478-198703000-00004","article-title":"Pathology of the thyroid in amiodarone-associated thyrotoxicosis.","volume":"11","author":"Smyrk","year":"1987","journal-title":"Am J Surg Pathol"},{"key":"2019041122200052900_R86","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/0002-8703(89)90602-9","article-title":"Amiodarone-induced thyroiditis.","volume":"118","author":"Leung","year":"1989","journal-title":"Am Heart J"},{"key":"2019041122200052900_R87","first-page":"622","author":"Meurisse"},{"key":"2019041122200052900_R88","first-page":"1114","article-title":"Amiodarone-induced thyrotoxicosis: clinical presentation and expanded indications for thyroidectomy.","volume":"114","author":"Mulligan","year":"1993","journal-title":"Surgery"},{"key":"2019041122200052900_R89","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1001\/archinte.1993.00410070068010","article-title":"Thyrotoxicosis followed by hypothyroidism in patients treated with amiodarone. A possible consequence of a destructive process in the thyroid.","volume":"153","author":"Roti","year":"1993","journal-title":"Arch Intern Med"},{"key":"2019041122200052900_R90","first-page":"1273","article-title":"Iodine-induced subclinical hypothyroidism in euthyroid subjects with a previous episode of amiodarone-induced thyrotoxicosis.","volume":"75","author":"Roti","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122200052900_R91","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1507\/endocrj.46.443","article-title":"Clinical characteristics of amiodarone-induced thyrotoxicosis and hypothyroidism in Japan.","volume":"46","author":"Sato","year":"1999","journal-title":"Endocr J"},{"key":"2019041122200052900_R92","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1136\/pgmj.56.655.356","article-title":"Amiodarone-induced thyrotoxicosis: four cases and a review of the literature.","volume":"56","author":"Keidar","year":"1980","journal-title":"Postgrad J Med"},{"key":"2019041122200052900_R93","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/BF03347002","article-title":"Diagnosis of amiodarone-iodine-induced thyrotoxicosis (AIIT) associated with severe nonthyroidal illness.","volume":"10","author":"Balzano","year":"1987","journal-title":"J Endocrinol Invest"},{"key":"2019041122200052900_R94","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF03350098","article-title":"Suppression of thyroglobulin secretion in amiodarone iodine-induced thyrotoxicosis.","volume":"11","author":"Weissel","year":"1988","journal-title":"J Endocrinol Invest"},{"key":"2019041122200052900_R95","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1001\/archinte.1987.00370100095016","article-title":"Serum sex hormone-binding globulin in amiodarone-treated patients: A marker for tissue thyrotoxicosis.","volume":"147","author":"Bambini","year":"1987","journal-title":"Arch Intern Med"},{"key":"2019041122200052900_R96","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1365-2362.1984.tb01212.x","article-title":"Iodine-induced thyrotoxicosis: analysis of eighty-five consecutive cases.","volume":"14","author":"Leger","year":"1984","journal-title":"Eur J Clin Invest"},{"key":"2019041122200052900_R97","first-page":"444","article-title":"indication for subtotal thyroidectomy in patients with amiodarone-(iodine-)related hyperthyroidism.","volume":"18","author":"Blossey","year":"1988","journal-title":"Wiener Med Wochenschr"},{"key":"2019041122200052900_R98","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1001\/jama.1990.03440110092034","article-title":"Thyroidectomy for amiodarone induced thyrotoxicosis.","volume":"263","author":"Farwell","year":"1990","journal-title":"JAMA"},{"key":"2019041122200052900_R99","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/0002-8703(91)90488-4","article-title":"Amiodarone-induced hyperthyroidism: thyroidectomy under local anesthesia.","volume":"122","author":"Mehra","year":"1991","journal-title":"Am Heart J"},{"key":"2019041122200052900_R100","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-2125.1991.tb05548.x","article-title":"The effects of plasmapheresis on thyroid hormone and plasma drug concentrations in amiodarone-induced thyrotoxicosis.","volume":"31","author":"Uzzan","year":"1991","journal-title":"Br J Clin Pharmacol"},{"key":"2019041122200052900_R101","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/BF03348934","article-title":"Treatment of amiodarone iodine-induced thyrotoxicosis with plasmapheresis and methimazole.","volume":"16","author":"Aghini-Lombardi","year":"1993","journal-title":"J Endocrinol Invest"},{"key":"2019041122200052900_R102","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1046\/j.1365-2265.1996.00566.x","article-title":"Failure of plasmapheresis, corticosteroids and thionamides to ameliorate a case of protracted amiodarone-induced thyroiditis.","volume":"45","author":"Samaras","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041122200052900_R103","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0031-6997(24)01350-4","article-title":"Perchlorate and the thyroid gland.","volume":"50","author":"Wolff","year":"1998","journal-title":"Pharmacol Rev"},{"key":"2019041122200052900_R104","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/BF03348098","article-title":"Treatment of amiodarone associated thyrotoxicosis by simultaneous administration of potassium perchlorate and methimazole.","volume":"9","author":"Martino","year":"1986","journal-title":"J Endocrinol Invest"},{"key":"2019041122200052900_R105","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1136\/bmj.298.6687.1547","article-title":"Treatment of amiodarone induced hyperthyroidism with potassium perchlorate and methimazole during amiodarone treatment.","volume":"298","author":"Reichert","year":"1989","journal-title":"Br Med J"},{"key":"2019041122200052900_R106","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1177\/009127006200200603","article-title":"The relative toxicity of antithyroid drugs.","volume":"2","author":"Trotter","year":"1962","journal-title":"J New Drugs"},{"key":"2019041122200052900_R107","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1210\/jcem-58-1-62","article-title":"Similar effects of thionamide drugs and perchlorate on thyroid stimulating immunoglobulins in Graves\u2019 disease: evidence against immunosuppressive action of thionamide drugs.","volume":"58","author":"Wenzel","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122200052900_R108","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/BF03348187","article-title":"Failure to control hyperthyroidism with a thionamide after KClO4 withdrawal in a patient with amiodarone associated thyrotoxicosis.","volume":"10","author":"De Weweire","year":"1987","journal-title":"J Endocrinol Invest"},{"key":"2019041122200052900_R109","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0002-9343(97)00047-8","article-title":"Lithium treatment in amiodarone-induced thyrotoxicosis.","volume":"102","author":"Dickstein","year":"1997","journal-title":"Am J Med"},{"key":"2019041122200052900_R110","first-page":"2930","article-title":"Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study.","volume":"81","author":"Bartalena","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122200052900_R111","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1136\/bmj.284.6332.1835-a","article-title":"Prednisone in amiodarone-induced thyrotoxicosis.","volume":"284","author":"Wimpfheimer","year":"1982","journal-title":"Br Med J"},{"key":"2019041122200052900_R112","first-page":"2767","article-title":"Efficacite\u0300 de la dexamethasone dans le traitement de l\u2019hyperthyroidie a\u0300 l\u2019amiodarone.","volume":"13","author":"Simon","year":"1985","journal-title":"Presse Med"},{"key":"2019041122200052900_R113","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF03349916","article-title":"Rapid effectiveness of prednisone and thionamides combined therapy in severe amiodarone iodine-induced thyrotoxicosis. Comparison of two groups of patients with apparently normal thyroid glands.","volume":"12","author":"Broussolle","year":"1989","journal-title":"J Endocrinol Invest"},{"key":"2019041122200052900_R114","first-page":"235","article-title":"dexamethasone treatment of amiodarone-induced thyrotoxicosis (AIT) with or without persistent administration of the drug.","volume":"44","author":"Bonnyns","year":"1989","journal-title":"Acta Cardiol"},{"key":"2019041122200052900_R115","doi-asserted-by":"crossref","first-page":"594","DOI":"10.5694\/j.1326-5377.1985.tb113526.x","article-title":"Amiodarone. The dilemma of hyperthyroxinaemia and the treatment of thyrotoxicosis.","volume":"142","author":"Donaghue","year":"1985","journal-title":"Med J Aust"},{"key":"2019041122200052900_R116","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/hrt.79.2.121","article-title":"Amiodarone and the thyroid: a practical guide to the management of thyroid dysfunction induced by amiodarone therapy.","volume":"79","author":"Newman","year":"1998","journal-title":"Heart"},{"key":"2019041122200052900_R117","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1136\/bmj.305.6847.224","article-title":"Treatment of amiodarone induced thyrotoxicosis with carbimazole alone and continuation of amiodarone.","volume":"305","author":"Davies","year":"1992","journal-title":"Br Med J"},{"key":"2019041122200052900_R118","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1136\/hrt.72.3.266","article-title":"Two cases of amiodarone-induced thyrotoxicosis successfully treated with a short course of antithyroid drugs while amiodarone was continued.","volume":"72","author":"Trip","year":"1994","journal-title":"Br Heart J"},{"key":"2019041122200052900_R119","first-page":"269","article-title":"Etude prospective de l\u2019incidence des dysthyroidies survenant chez des patients traites par amiodarone.","volume":"38","author":"Chevigne\u0300-Brancart","year":"1983","journal-title":"Rev Med Liege"},{"key":"2019041122200052900_R120","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0002-9343(85)90336-5","article-title":"Effect of long-term amiodarone therapy on thyroid hormone levels and thyroid function.","volume":"78","author":"Borowski","year":"1985","journal-title":"Am J Med"},{"key":"2019041122200052900_R121","first-page":"199","article-title":"Amiodarone and the thyroid gland: a review.","volume":"36","author":"Jonckheer","year":"1981","journal-title":"Acta Cardiol"},{"key":"2019041122200052900_R122","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/0002-9343(84)90379-6","article-title":"Myxedema coma during long-term amiodarone therapy.","volume":"77","author":"Mazonson","year":"1984","journal-title":"Am J Med"},{"key":"2019041122200052900_R123","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1001\/archinte.1985.00360060072009","article-title":"Amiodarone-induced hypothyroidism: a common complication of prolonged therapy. A report of eight cases.","volume":"145","author":"Hawthorne","year":"1985","journal-title":"Arch Intern Med"},{"key":"2019041122200052900_R124","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1210\/jcem-32-4-515","article-title":"Enhanced susceptibility to iodide myxedema in patients with Hashimoto\u2019s disease.","volume":"32","author":"Braverman","year":"1971","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122200052900_R125","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1210\/endo-45-5-504","article-title":"The temporary nature of the inhibition action of excess iodide on organic iodine synthesis in the normal thyroid.","volume":"45","author":"Wolff","year":"1949","journal-title":"Endocrinology"},{"key":"2019041122200052900_R126","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1530\/eje.0.1400241","article-title":"Amiodarone compared with iodine exhibits a potent and persistent inhibitory effect on TSH-stimulated cAMP production in vitro: a possible mechanism to explain amiodarone-induced hypothyroidism.","volume":"140","author":"Pitsiavas","year":"1999","journal-title":"Eur J Endocrinol"},{"key":"2019041122200052900_R127","first-page":"95","article-title":"Amiodarone et fonction thyroidienne. Difficultes diagnostiques et therapeutiques.","volume":"37","author":"Wemeau","year":"1982","journal-title":"Therapie"},{"key":"2019041122200052900_R128","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/0002-8703(84)90751-8","article-title":"Chronic administration of amiodarone and thyroid function: a follow-up study.","volume":"108","author":"Sanmarti","year":"1984","journal-title":"Am Heart J"},{"key":"2019041122200052900_R129","doi-asserted-by":"crossref","first-page":"553","DOI":"10.7326\/0003-4819-113-7-553","article-title":"Amiodarone-induced elevation of thyroid stimulating hormone in patients receiving levothyroxine for primary hypothyroidism.","volume":"113","author":"Figge","year":"1990","journal-title":"Ann Intern Med"},{"key":"2019041122200052900_R130","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1210\/jcem-63-5-1233","article-title":"Short term administration of potassium perchlorate restores euthyroidism in amiodarone iodine-induced hypothyroidism.","volume":"63","author":"Martino","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041122200052900_R131","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/0002-8703(91)90489-5","article-title":"Fetal and neonatal adverse effects profile of amiodarone treatment during pregnancy.","volume":"122","author":"Widerhorn","year":"1991","journal-title":"Am Heart J"},{"key":"2019041122200052900_R132","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/0002-9149(83)90377-6","article-title":"Amiodarone therapy during pregnancy.","volume":"51","author":"McKenna","year":"1983","journal-title":"Am J Cardiol"},{"key":"2019041122200052900_R133","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0140-6736(83)92853-2","article-title":"Amiodarone in pregnancy.","volume":"1","author":"Pitcher","year":"1983","journal-title":"Lancet"},{"key":"2019041122200052900_R134","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0002-9378(85)80120-4","article-title":"Transplacental treatment of tachycardia-induced fetal heart failure with verapamil and amiodarone.","volume":"153","author":"Rey","year":"1985","journal-title":"Am J Obstet Gynecol"},{"key":"2019041122200052900_R135","first-page":"959","article-title":"Effects of amiodarone during pregnancy.","volume":"136","author":"Rey","year":"1987","journal-title":"Can Med Assoc J"},{"key":"2019041122200052900_R136","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/pgmj.61.711.75","article-title":"Use of amiodarone during pregnancy.","volume":"61","author":"Robson","year":"1985","journal-title":"Postgrad Med J"},{"key":"2019041122200052900_R137","first-page":"134","article-title":"Treatment of fetal cardiac arrhythmias.","volume":"34","author":"Wladimiroff","year":"1985","journal-title":"Br J Hosp Med"},{"key":"2019041122200052900_R138","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0167-5273(88)90285-9","article-title":"Amiodarone in pregnancy. Case report and review of the literature.","volume":"20","author":"Foster","year":"1988","journal-title":"Int J Cardiol"},{"key":"2019041122200052900_R139","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/0002-9149(85)90596-X","article-title":"Amiodarone in pregnancy.","volume":"56","author":"Penn","year":"1985","journal-title":"Am J Cardiol"},{"key":"2019041122200052900_R140","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0002-9149(87)80095-4","article-title":"Amiodarone and digoxin for refractory fetal tachycardia.","volume":"59","author":"Arnoux","year":"1987","journal-title":"Am J Cardiol"},{"key":"2019041122200052900_R141","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/0002-9149(87)91070-8","article-title":"Neonatal hypothyroidism after treatment by amiodarone during pregnancy.","volume":"60","author":"Laurent","year":"1987","journal-title":"Am J Cardiol"},{"key":"2019041122200052900_R142","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/ehj\/9.1.106","article-title":"Amiodarone during pregnancy.","volume":"9","author":"Strunge","year":"1988","journal-title":"Eur Heart J"},{"key":"2019041122200052900_R143","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1651-2227.1988.tb10717.x","article-title":"Congenital hypothyroid goiter and amiodarone.","volume":"77","author":"de Wolf","year":"1988","journal-title":"Acta Paediatr Scand"},{"key":"2019041122200052900_R144","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/0002-8703(89)90028-8","article-title":"Repeated intravascular treatment with amiodarone in a fetus with refractory supraventricular tachycardia and hydrops fetalis.","volume":"118","author":"Gembruch","year":"1989","journal-title":"Am Heart J"},{"key":"2019041122200052900_R145","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1089\/thy.1992.2.279","article-title":"Outcome of thyroid function in newborns from mothers treated with amiodarone.","volume":"2","author":"Matsumura","year":"1992","journal-title":"Thyroid"},{"key":"2019041122200052900_R146","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0028-2243(92)90174-W","article-title":"Use of amiodarone during pregnancy.","volume":"43","author":"Plomp","year":"1992","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2019041122200052900_R147","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/pd.1970120903","article-title":"Amiodarone treatment in pregnancy for dilatative cardiomyopathy with ventricular malignant extrasystole and normal maternal and neonatal outcome.","volume":"12","author":"Valensise","year":"1992","journal-title":"Prenat Diagn"},{"key":"2019041122200052900_R148","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/pd.1970140819","article-title":"Fetal hypothyroidism as a complication of amiodarone treatment for persistent fetal supraventricular tachycardia.","volume":"14","author":"de Catte","year":"1994","journal-title":"Prenat Diagn"},{"key":"2019041122200052900_R149","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/0002-9378(95)91498-6","article-title":"Pregnancy outcome after gestational exposure to amiodarone in Canada.","volume":"172","author":"Magee","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"2019041122200052900_R150","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/BF03350801","article-title":"Transient neonatal hypothyroidism after gestational exposure to amiodarone: a follow-up of two cases.","volume":"21","author":"Grosso","year":"1998","journal-title":"J Endocrinol Invest"},{"key":"2019041122200052900_R151","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0892-0362(98)00052-X","article-title":"Neurodevelopment after in utero amiodarone exposure.","volume":"21","author":"Magee","year":"1999","journal-title":"Neurotoxicol Teratol"},{"key":"2019041122200052900_R152","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/BF03343825","article-title":"Effects of amiodarone administration during pregnancy on neonatal thyroid function and subsequent neurodevelopment.","volume":"24","author":"Bartalena","year":"2001","journal-title":"J Endocrinol Invest"}],"container-title":["Endocrine Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/edrv\/article-pdf\/22\/2\/240\/8860787\/edrv0240.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T12:01:54Z","timestamp":1746100914000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/edrv\/article\/22\/2\/240\/2424097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,4,1]]},"references-count":152,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,11,7]]},"published-print":{"date-parts":[[2001,4,1]]}},"URL":"https:\/\/doi.org\/10.1210\/edrv.22.2.0427","relation":{},"ISSN":["0163-769X","1945-7189"],"issn-type":[{"value":"0163-769X","type":"print"},{"value":"1945-7189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,4,1]]}}}